Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Jaglowski · SciRah

Researcher profile · Semantic Scholar

S. Jaglowski

Share profile

S. Jaglowski — researcher profile on SciRah

h-index: 48
Works: 317
Citations: 16K

Most-cited papers

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
S. Schuster, C. Tam, P. Borchmann, N. Worel +25 more
2021The Lancet Oncology440 citations Open access
Semantic Scholar
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Michael Wang, J. Muñoz, A. Goy, F. Locke +21 more
2022Journal of Clinical Oncology271 citations Open access
Semantic Scholar
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
J. Zurko, J. Ramdial, M. Shadman, Saira S. Ahmed +38 more
2022Haematologica83 citations Open access
Semantic Scholar
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
R. Merryman, L. Castagna, L. Giordano, V. Ho +62 more
2021Leukemia81 citations
Semantic Scholar
CAR T-cell therapy for B-cell lymphoma
N. Denlinger, David Bond, S. Jaglowski
2021Current Problems in Cancer77 citations Open access
Semantic Scholar
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
M. Elsawy, J. Chavez, I. Avivi, J. Larouche +27 more
2022Blood72 citations Open access
Semantic Scholar
Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma
Jonathan E. Brammer, Zachary Braunstein, Aashish Katapadi, K. Porter +21 more
2021Journal for ImmunoTherapy of Cancer54 citations Open access
Semantic Scholar
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma
G. Shouse, A. Kaempf, Max J. Gordon, A. Artz +19 more
2023Blood Advances48 citations Open access
Semantic Scholar
Autologous and Allogeneic Hematopoietic Cell Transplantation for Diffuse Large B-cell Lymphoma-Type Richter Syndrome.
A. Herrera, K. Ahn, C. Litovich, Yue Chen +26 more
2021Blood Advances47 citations Open access
Semantic Scholar
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
A. Kittai, D. Bond, Ying Huang, S. Bhat +29 more
2024Journal of Clinical Oncology43 citations
Semantic Scholar
Selinexor combined with ibrutinib demonstrates tolerability and safety in advanced B-cell malignancies: A phase I study
D. Stephens, Ying Huang, A. Ruppert, J. Walker +14 more
2022Clinical Cancer Research26 citations Open access
Semantic Scholar
Ibrutinib in Steroid-Refractory Chronic Graft-Versus-Host Disease, a Single-Center Experience.
Kuo-Kai Chin, Haesook T. Kim, Eno-Abasi Inyang, V. Ho +9 more
2021Transplantation and Cellular Therapy26 citations Open access
Semantic Scholar
Cutaneous manifestations of chimeric antigen receptor T cell therapy: an introduction for dermatologists.
K. Nusbaum, Brittany Dulmage, Jennifer N. Choi, S. Jaglowski +1 more
2021Journal of American Academy of Dermatology24 citations
Semantic Scholar
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience
A. Schaefer, Ying Huang, A. Kittai, J. Maakaron +6 more
2021Cancer Management and Research23 citations Open access
Semantic Scholar
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry
D. Landsburg, M. Frigault, Michael Heim, S. R. Foley +15 more
2025Journal for ImmunoTherapy of Cancer22 citations Open access
Semantic Scholar
Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry
D. Landsburg, M. Frigault, M. Heim, S. R. Foley +15 more
2022Blood21 citations Open access
Semantic Scholar
Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B Cell Lymphoma
P. Munshi, Yue Chen, K. Ahn, Farrukh T. Awan +14 more
2022Transplantation and Cellular Therapy17 citations Open access
Semantic Scholar
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
U. Jaeger, C. Tam, P. Borchmann, Jospeh P. McGuirk +26 more
2022Blood Advances16 citations Open access
Semantic Scholar
Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults
S. Vasu, Matthew Bostic, Qiu-Hong Zhao, Nidhi Sharma +18 more
2021Blood Advances16 citations Open access
Semantic Scholar
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes.
Malika Kapadia, L. Lehmann, Jeffrey J. Auletta, Lisa Beatty +30 more
2022Transplantation and Cellular Therapy15 citations Open access
Semantic Scholar
Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor
Zachary D. Crees, M. Rettig, A. Bashey, S. Devine +11 more
2023Blood Advances14 citations Open access
Semantic Scholar
Intrathecal Chemotherapy: An Alternative Treatment Strategy to Prolonged Corticosteroids for Severe CAR T Associated Neurotoxicity
Filiz Yucebay, J. Maakaron, A. Grana, S. Jaglowski +1 more
2020Biology of Blood and Marrow Transplantation13 citations Open access
Semantic Scholar
A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease.
J. Magenau, S. Jaglowski, J. Uberti, S. Farag +16 more
2023Blood12 citations Open access
Semantic Scholar
Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma
A. Sigmund, N. Denlinger, Ying Huang, D. Bond +10 more
2022Transplantation and Cellular Therapy10 citations Open access
Semantic Scholar
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience
Justin Jiang, A. Sigmund, Qiu-Hong Zhao, P. Elder +19 more
2021Cancers10 citations Open access
Semantic Scholar
Outcomes of Patients (Pts) in ZUMA-9, a Multicenter, Open-Label Study of Axicabtagene Ciloleucel (Axi-Cel) in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL) for Expanded Access and Commercial Out-of-Specification (OOS) Product
C. Jacobson, F. Locke, D. Miklos, J. Vose +13 more
202010 citations
Semantic Scholar
Outcomes with KTE-X19 in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) in ZUMA-2 who had progression of disease within 24 months of diagnosis (POD24).
Michael L. Wang, J. Muñoz, A. Goy, F. Locke +16 more
20219 citations
Semantic Scholar
Real-World Efficacy and Safety Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry
D. Landsburg, M. Frigault, Zhen-Huan Hu, S. Jaglowski +13 more
2021Blood9 citations Open access
Semantic Scholar
Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem
Jane Koo, Jeffrey J. Auletta, D. Hartley, John Huber +12 more
2022Transplantation and Cellular Therapy8 citations Open access
Semantic Scholar
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant
A. Sigmund, Qiu-Hong Zhao, Justin Jiang, P. Elder +17 more
2022Frontiers in Oncology8 citations Open access
Semantic Scholar
Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation
Nidhi Sharma, M. Faisal, Qiu-Hong Zhao, Justin Jiang +19 more
2021Journal of Clinical Medicine8 citations Open access
Semantic Scholar
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
R. Chakraborty, Jean C. Yi, L. Rybicki, Jaime M. Preussler +23 more
2023Transplantation and Cellular Therapy7 citations Open access
Semantic Scholar
Health Related Quality of Life in Young Adults Survivors of Hematopoietic Cell Transplantation
S. Rotz, Jean C. Yi, B. Hamilton, Wei Wei +21 more
2022Transplantation and Cellular Therapy7 citations Open access
Semantic Scholar
Impact of Comorbidities on Outcomes and Toxicity in Patients Treated with CAR T-Cell Therapy for Diffuse Large B Cell Lymphoma (DLBCL): A Multicenter Rwe Study
G. Shouse, A. Kaempf, David Yashar, A. Sigmund +16 more
2021Blood7 citations
Semantic Scholar
KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): Results of the Phase 2 ZUMA-2 Study
Michael L. Wang, J. Muñoz, A. Goy, F. Locke +16 more
20207 citations Open access
Semantic Scholar
Improved Overall Survival with Axicabtagene Ciloleucel Vs Standard of Care in Second-Line Large B-Cell Lymphoma Among the Elderly: A Subgroup Analysis of ZUMA-7
M. J. Kersten, Umar Farooq, A. Rapoport, F. Locke +21 more
2023Blood6 citations Open access
Semantic Scholar
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter's Transformation: An International Multicenter Retrospective Study
A. Kittai, D. Bond, Ying Huang, S. Bhat +28 more
2023Blood6 citations Open access
Semantic Scholar
Cell Therapy Informatics: Updates on the integration of HCT/IEC functionalities into an electronic medical record system in the US to promote efficiency, patient safety, research, and data interoperability.
V. Ho, T. Klumpp, Wayne H. Liang, Matthew Prestegaard +9 more
2023Transplantation and Cellular Therapy6 citations Open access
Semantic Scholar
CAR T-Cell Therapy: Clinical Outcomes, Patient Selection and Financial Metrics with Tisagenlecleucel and Axicabtagene Ciloleucel, a Single Center Experience
N. Denlinger, Zachary Braunstein, Akwasi Agyeman, Zebulun Purdin +10 more
2020Biology of Blood and Marrow Transplantation5 citations Open access
Semantic Scholar
Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with T-Cell Malignancies: Final Results of a Phase I/II Trial
C. Hosing, Zachary Braunstein, E. McLaughlin, B. Valdez +17 more
2023Blood4 citations Open access
Semantic Scholar
Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil
Ashley N. Gray, C. Avila, C. Chung, L. Seminario-Vidal +7 more
2023JAAD Case Reports4 citations Open access
Semantic Scholar
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents
M. Faisal, W. Hanel, T. Voorhees, Rui Li +16 more
2023Cancer Medicine4 citations Open access
Semantic Scholar
Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib
A. Sigmund, Ying Huang, A. Ruppert, K. Maddocks +7 more
2022Leukemia4 citations
Semantic Scholar
Association between post-CART terminal complement complex (TCC) levels and clinically significant immune effector cell–associated neurotoxicity syndrome (ICANS).
George Iii, Qiu-Hong Zhao, T. Voorhees, N. Denlinger +16 more
2024Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplant Survivors
Sanghee Hong, Jing Zhao, Shu Wang, Han Wang +28 more
2022Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Post‐relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation
Saira S. Ahmed, Qiu-Hong Zhao, W. Hanel, M. Qazilbash +10 more
2021Hematological Oncology3 citations
Semantic Scholar
Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients
Cecelia R. Miller, Ying Huang, A. Ruppert, J. Labanowska +12 more
2021Leukemia3 citations Open access
Semantic Scholar
Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation
Cooper J. Quartermaine, Zachary Braunstein, Adnan Shaaban, Alma Habib +20 more
2025Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease2 citations Open access
Semantic Scholar
Association between Post-CART Terminal Complement Complex Levels and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
Evandro D. Bezerra, George Durisek, Qiu-Hong Zhao, N. Denlinger +17 more
2024Blood2 citations
Semantic Scholar
Durable Efficacy and Manageable Safety in Patients Age ≥ 75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting
D. Landsburg, Michael Heim, A. Moskop, S. R. Foley +15 more
2023Blood2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Jacobson×12
Invite
C. Jacobson — researcher profile on SciRah
S. Vasu×12
Invite
S. Vasu — researcher profile on SciRah
S. Penza×12
Invite
S. Penza — researcher profile on SciRah
F. Locke×11
Invite
F. Locke — researcher profile on SciRah

×11

Invite

J. Brammer — researcher profile on SciRah

Invite

A. Sigmund — researcher profile on SciRah

Invite

A. Kittai — researcher profile on SciRah

Invite

B. Hill — researcher profile on SciRah

N. Denlinger×7

Invite

N. Denlinger — researcher profile on SciRah

Invite

D. Bond — researcher profile on SciRah

Invite

Ying Huang — researcher profile on SciRah

Invite

S. Wall — researcher profile on SciRah